Hongyi Wu Selected Research

Hongyi Wu Research Topics

Disease

6	Myocardial Infarction 01/2023 - 01/2012
6	Acute Coronary Syndrome 01/2022 - 01/2012
4	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023 - 01/2019
4	Hemorrhage 01/2023 - 08/2016
4	Neoplasms (Cancer) 01/2023 - 01/2018
3	Thrombosis (Thrombus) 01/2023 - 10/2014
2	Embolism (Embolus) 01/2023 - 08/2016
2	Ischemic Stroke 01/2023 - 01/2023
2	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 12/2021 - 01/2021
1	Insulin Resistance 10/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Coronary Disease (Coronary Heart Disease) 01/2023
1	Disease Progression 01/2023
1	Hyperlipidemias (Hyperlipidemia) 09/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022
1	Ganglion Cysts (Ganglion) 12/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	ST Elevation Myocardial Infarction 10/2020
1	Stroke (Strokes) 10/2020
1	Death (Near-Death Experience) 10/2020
1	Non-ST Elevated Myocardial Infarction 10/2020
1	Aneurysm (Aneurysms) 05/2020
1	Neoplasm Metastasis (Metastasis) 05/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Thrombophilia 01/2019
1	Bradycardia 01/2018
1	Atrioventricular Block 01/2018
1	Cardiomyopathies (Cardiomyopathy) 12/2017
1	Left Ventricular Dysfunction 12/2017
1	Rupture 08/2016
1	Embolism and Thrombosis 08/2016
1	Bacterial Endocarditis 08/2016
1	Dysarthria (Spastic Dysarthria) 08/2016
1	Dyspnea (Shortness of Breath) 10/2014
1	Hyperplasia 02/2008

Drug/Important Bio-Agent (IBA)

5	Clopidogrel (Plavix)FDA Link 01/2023 - 01/2012
4	TicagrelorIBA 10/2020 - 10/2014
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 05/2020
3	Adenosine (Adenocard)FDA LinkGeneric 01/2023 - 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 10/2023
1	Triglycerides (Triacylglycerol)IBA 10/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2023
1	TroponinIBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2023
1	Dobutamine FDA LinkGeneric 01/2023
1	MCOIBA 01/2023
1	indobufenIBA 01/2023
1	PeroxidesIBA 09/2022
1	AntioxidantsIBA 09/2022
1	LipidsIBA 09/2022
1	MagnesiumIBA 02/2022
1	B7-H1 AntigenIBA 01/2022
1	CholesterolIBA 01/2022
1	RotenoneIBA 12/2021
1	Oxidopamine (6 Hydroxydopamine)IBA 12/2021
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 12/2021
1	SynucleinsIBA 12/2021
1	Cilostazol (Pletal)FDA LinkGeneric 04/2021
1	ATH434IBA 01/2021
1	AR C124910XXIBA 10/2020
1	omega-Chloroacetophenone (Mace)IBA 10/2020
1	Opioid Analgesics (Opioids)IBA 10/2020
1	NLR ProteinsIBA 01/2020
1	hepsinIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	olaparibIBA 01/2020
1	asparagine-glycine-arginineIBA 01/2018
1	GoldIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Sulfhydryl Compounds (Thiols)IBA 01/2018
1	CD13 Antigens (Alanine Aminopeptidase)IBA 01/2018
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2018
1	AnticoagulantsIBA 08/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2016
1	FibrinIBA 03/2014
1	Thrombin FDA Link 03/2014
1	Cytochrome P-450 CYP2C19IBA 01/2012

Therapy/Procedure

5	Stents 01/2023 - 02/2008
5	Therapeutics 05/2020 - 10/2014
4	Percutaneous Coronary Intervention 10/2020 - 01/2012
2	Drug-Eluting Stents 01/2023 - 01/2019
1	Drug Therapy (Chemotherapy) 02/2022
1	Lymph Node Excision (Lymph Node Dissection) 05/2020
1	Intravenous Injections 01/2018
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2017
1	Extracorporeal Shockwave Therapy 12/2017